Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v4-FR Version v2-FR
Language French French
Date Updated 2020-04-17 2020-03-20
Drug Identification Number 02250527 02250527
Brand name LESCOL XL LESCOL XL
Common or Proper name LESCOL XL 80MG 2X14 LESCOL XL 80MG 2X14
Company Name NOVARTIS PHARMACEUTICALS CANADA INC NOVARTIS PHARMACEUTICALS CANADA INC
Ingredients FLUVASTATIN FLUVASTATIN
Strength(s) 80MG 80MG
Dosage form(s) TABLET (EXTENDED-RELEASE) TABLET (EXTENDED-RELEASE)
Route of administration ORAL ORAL
Packaging size 2X14 2X14
ATC code C10AA C10AA
ATC description LIPID MODIFYING AGENTS, PLAIN LIPID MODIFYING AGENTS, PLAIN
Reason for discontinuation Manufacturing issues Manufacturing issues
Anticipated discontinuation date 2020-04-03 2020-04-03
Actual discontinuation date 2020-04-03
Remaining supply date 2020-04-03 2020-04-03
Discontinuation status Discontinued To be discontinued
Discontinuation decision reversal no no
Tier 3 Status No No
Information on remaining supply
Company comments
Health Canada comments